期刊文献+

起搏器植入术后对三尖瓣反流的远期影响 被引量:13

Long-term effects of permanent pacemaker implantation on tricuspid valve regurgitation
原文传递
导出
摘要 目的分析永久心脏起搏器植入术后三尖瓣反流(TR)的远期发生率及影响因素,研究其对心脏结构及功能的影响,探讨其发生机制。方法选取解放军总医院心血管外科2000年1月至2011年6月为行永久心脏起搏器更换手术住院的患者共430例,共筛选出心脏超声等资料完整的108例患者资料进行回顾性分析。根据术后随访心脏超声检查确定的TR的程度将所有患者分为三尖瓣正常组(79例)和三尖瓣异常组(29例),对两组患者临床及超声资料进行比较及多因素回归分析。结果平均随访时间(距首次起搏器植入手术时间)4-34(13±6)年。术前三尖瓣功能正常的108例患者在植入永久心脏起搏器术后远期随访共有29例(26.9%)发现有意义的Try(1.5-3级)。与三尖瓣正常组比较,在起搏器植入术后三尖瓣异常组中,距首次植入起搏器的时间(年)更长(16±7比12±5,P=0.003);跨三尖瓣口电极数(根)更多(1.31±0.66比1.10±0.30,P=0.026);术前右房径(mm)更大(38±7比35±4,P=0.028);术前轻度三尖瓣及二尖瓣反流(MR)率更高(TR:21%比4%、P=0.015,MR:28%比5%、P=0.003)。在起搏器植入术后三尖瓣异常组的随访超声数据右房径、右室径、左房径及二尖瓣异常反流率均明显高于三尖瓣正常组,而左室射血分数明显低于三尖瓣正常组。结论心脏起搏器植入术后远期有意义的TR并不少见,起搏器植入时间、跨三尖瓣口电极数、术前右房大小及术前存在轻度的MR、TR是影响起搏器植入术后远期TR的相关因素。 Objective To explore the long-term effects of permanent pacemaker implantation (PPI)on tricuspid valve regurgitation (TR) in Chinese patients so as to determine the incidence and related factors, evaluate its effects on heart structure and function and ascertain the exact mechanism of TR after PPI. Methods A total of 430 patients undergoing permanent pacemaker replacement at our hospital between January 2000 and June 2011 were recruited. The patients with isolated atrial lead implantation procedures, significant heart valve disease or chronic obstructive pulmonary disease were excluded. The data of 108 patients who had Doppler echocardiograms performed before the first pacemaker implantation procedure and this pacemaker replacement procedure were obtained and retrospectively analyzed. According to the postimplant grade of TR, the patients were divided into two groups : normal tricuspid ( n =79 ) and abnormal tricuspid(n = 29 ). Their clinical characteristics and echocardiographic data between two groups were analyzed and compared. Results The mean follow-up time (from the first pacemaker implantation) was ( 13 ± 6) years( range : 4 - 34). Among 108 patients with initially normal tricuspid post-implant, 29 patients (26. 9% ) developed significant TR during the follow-up. In comparison to those in normal tricuspid group, the patients in abnormal tricuspid group had a longer time from the first pacemaker implantation ( ( 16 ±7 ) vs ( 12 ± 5 ) years, P = 0. 003 ), more transtricuspid leads ( 1.31 ±0. 66 vs 1.10 ± 0. 30, P = 0. 026 ), larger right atrial size ( (38±7) vs (35 ±4) mm, P =0. 028) and higher prevalence of mild TR and mitral valve regurgitation (MR) pre-implantation(TR: 21% vs 4%, P =0. 015 ,MR: 28% vs 5% , P =0. 003). The size of right atrium, right ventricle and left atrium in abnormal tricuspid group were more than those in normal tricuspid group. The prevalence of significant MR post-implantation in abnormal tricuspid group was higher than that in normal tricuspid group. The ejection fraction in abnormal tricuspid group was lower than that in normal tricuspid group during the follow-up. Conclusions Abnormal TR after PPI during a long-term follow-up is quite common. The related factors include the time interval from the first pacemaker implantation, number of transtricuspid lead, right atrial size, mild TR and MR pre-implantation.
出处 《中华医学杂志》 CAS CSCD 北大核心 2012年第30期2118-2122,共5页 National Medical Journal of China
关键词 心脏起搏器 人工 三尖瓣闭锁不全 心脏功能试验 超声心动描记术 Pacemaker, artificial Tricuspid valve insufficiency Heart function tests Echocardiography
  • 相关文献

参考文献18

  • 1Rogers JH, Boiling SF. The tricuspid valve current perspective and evolving management of tricuspid regurgitation. Circulation, 2009,119:2718-2725.
  • 2沈法荣,郑良荣,徐耕.超声心动图与心脏起搏//叶萌.现代心脏起搏治疗学.上海:上海科学技术出版社,2004:466-471.
  • 3Zoghbi WA, Enriquez-Sarano M, Foster E, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two dimensional and Doppler echocardiography. J Am Soc Echocardiogr, 2003,16:777-802.
  • 4Cairns BBK, Klaster FE, Bristow JD, et al. Problems in the hemodynamie diagnosis of tricuspid insufficiency. Am Heart J, 1968,75 : 174-179.
  • 5Jacobs P, Vandenbossche JL, de Marneffe M, et al. Pseudo tricuspid regurgitation in ventricular pacing. Am Heart J, 1985, 110:886-888.
  • 6Paniagu D, Aldrich H, Lieberman E, et al. Increased prevalence of significant tricuspid regurgitation in patients with transvenous pacemakers leads. Am J Cardiol, 1998, 82 : 1130-1132.
  • 7Kim JB, Spevack DM, Tunick PA~ et al. The effect of transvenous pacemaker and implantable cardioverter defibrillator lead placement on tricuspid valve function: an observational study. J Am Soc Eehocardiogr, 2008,21:284-287.
  • 8Klutstein M, Balkin J, Butnaru A, et al. Tricuspid incompetence following permanent pacemaker implantation. PACE Pacing Clin Electrophysiol, 2009,32 :S135-S137.
  • 9Leibowitz DW, Rosenheck S, Pollak A, et al. Transvenous pacemaker leads do not women tricuspid regurgitation : a prospective echocardiographic study. Cardiology, 2000,93:74-77.
  • 10DeCock C, Vinkers M, Campe LV, et al. Long-term outcome of patients with multiple noninfected transvenous leads : a clinical and echocardiographic study pacing. Clin Electrophysiol, 2000, 23 : 423- 426.

二级参考文献24

  • 1Wilkoff BL, Cook JR, Epstein AE, et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA, 2002, 288: 3115-3123.
  • 2Mukharji J, Rehr RB, Hastillo A, et al. Comparison of atrial contribution to cardiac hemodynamics in patients with normal and severely compromised cardiac function. Clin Cardiol, 1990, 13 : 639-643.
  • 3Lamas GA, Lee KL, Sweeney MO, et al. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med, 2002, 346: 1854-1862.
  • 4Toff WD, Camm AJ, Skehan JD , et al. Single-chamber versus dual-chamber pacing for high-grade atrioventricular block. N Engl J Med, 2005, 353 : 145-155.
  • 5Saccomanno G, Fraticelli A, Marini M, et al. Permanent ventricular and dual chamber cardiac stimulation: role of pacing mode in relation to chronic atrial fibrillation risk and stroke development. Arch Gerontol Geriatr, 1999, 29 : 61-74.
  • 6Connolly SJ, Kerr CR, Gent M, et al. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators. N Engl J Med, 2000, 342: 1385-1391.
  • 7Tang AS, Roberts RS, Kerr C, et al. Relationship between pacemaker dependency and the effect of pacing mode on cardiovascular outcomes. Circulation, 2001, 103: 3081-3085.
  • 8Kruse I, Amman K, Conradson TB, et al. A comparison of the acute and long-term hemodynamic effects of ventricular inhibited and atrial synchronous ventricular inhibited pacing. Circulation, 1982, 65: 846-855.
  • 9Nielsen JC, Kristensen L, Andersen HR. A randomized comparison of atrial and dual-chamber pacing in 177 consecutive patients with sick sinus syndrome: echocardiographic and clinical outcome. J Am Coll Cardiol, 2003, 42: 614-623.
  • 10Kataoka H. Pacemaker-induced mitral regurgitation as a cause of refractory congestive heart filure during pacing therapy in a patient with hypertrophic obstructive cardiomyopathy. Congest Heart Fail, 2006,12:112.

共引文献13

同被引文献48

  • 1潘翠珍,舒先红,章朝霞,黄国倩,陆文良,葛均波,陈灏珠.经胸实时三维超声心动图定位起搏电极导线的可行性研究[J].中国超声医学杂志,2004,20(8):588-591. 被引量:8
  • 2吴棘,邓燕,郭盛兰,张棣,葛亮,潘永寿.经胸二维和实时三维超声对人工心脏起搏器电极导线位置的观察[J].临床超声医学杂志,2005,7(6):364-366. 被引量:6
  • 3金海,徐志云,王为.严重高脂血症致瓣膜病变1例[J].中华胸心血管外科杂志,2006,22(1):50-50. 被引量:1
  • 4刘丽,赵玉生,王士雯,何耀,陈瑞,李彦华,许强,黄广勇.北京地区军队老年人群退行性心脏瓣膜病流行病学研究[J].中华流行病学杂志,2006,27(10):836-839. 被引量:40
  • 5Leibowitz DW, Rosenheck S, Pollak A, et al. Transvenous pace- maker leads do not worsen tricuspid regurgitation: a prospective ech- ocardiographic study[ J]. Cardiology, 2000,93 ( 1-2 ) :74.
  • 6Seo Y, Ishizu T, Nakajima H, et al. Clinical utility of 3-dimension- al echocardiography in the evaluation of tricuspid regurgitation caused by pacemaker leads[ J]. C irc J, 2008,72 (9) :1 465.
  • 7Paniagua D, Aldrich HR, Lieberman EH, et al. Increased preva- lence of significant tricuspid regurgitation in patients with trans- venous pacemakers leads[J]. Am J Cardiol, 1998,82(9) :1 130.
  • 8Kim JB, Spevack DM, Tunick PA, et al. The effect of transvenous pacemaker and implantable cardioverter defibrillator lead placement on tricuspid valve function: an observational study [ J ]. J Am Soc Echocardiogr, 2008,21 (3) :284.
  • 9Klutstein M, Balkin J, Butnaru A, et al. Tricuspid incompetence following permanent pacemaker implantation [ J ]. Pacing Clin Elec- trophysiol, 2009,32 Suppl 1 : S135.
  • 10Lin G, Nishimura RA, Connolly HM, et al. Severe symptomatic tri- cuspid valve regurgitation due to permanent pacemaker or implant- able cardioverter-defibrillator leads [ J ]. J Am Coll Cardiol, 2005, 45(10) :1 672.

引证文献13

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部